139 related articles for article (PubMed ID: 11366693)
1. Amprenavir (Agenerase) receives FDA approval. Food and Drug Administration.
Highleyman L
BETA; 1999 Apr; 12(2):3. PubMed ID: 11366693
[TBL] [Abstract][Full Text] [Related]
2. Drug approval.
AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532
[TBL] [Abstract][Full Text] [Related]
3. Amprenavir, new protease inhibitor, approved.
James JS
AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
[TBL] [Abstract][Full Text] [Related]
4. Amprenavir approved.
STEP Perspect; 1999; 99(2):8. PubMed ID: 11366753
[TBL] [Abstract][Full Text] [Related]
5. Amprenavir: a new protease inhibitor nears approval.
Highleyman L
BETA; 1999 Jan; 12(1):8-9. PubMed ID: 11367244
[TBL] [Abstract][Full Text] [Related]
6. Amprenavir (Agenerase).
Simmons P
Res Initiat Treat Action; 1999 Jul; 5(3):7-10. PubMed ID: 11366726
[TBL] [Abstract][Full Text] [Related]
7. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
[TBL] [Abstract][Full Text] [Related]
8. Expanded access program begins.
Highleyman L
BETA; 1998 Oct; ():3. PubMed ID: 11365989
[TBL] [Abstract][Full Text] [Related]
9. Glaxo Wellcome's two new drugs.
Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081
[TBL] [Abstract][Full Text] [Related]
10. Agenerase approved by FDA.
Gaylord G
Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
[No Abstract] [Full Text] [Related]
11. Amprenavir (Agenerase) now available in expanded access.
AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864
[TBL] [Abstract][Full Text] [Related]
12. New protease inhibitor.
Vazquez E
Posit Aware; 1999; 10(3):24. PubMed ID: 11366764
[TBL] [Abstract][Full Text] [Related]
13. Expanded access.
Proj Inf Perspect; 1999 Apr; (27):13. PubMed ID: 11366730
[TBL] [Abstract][Full Text] [Related]
14. Study: new drug doesn't display cross-resistance.
AIDS Alert; 1999 Jul; 14(7):77. PubMed ID: 11366418
[TBL] [Abstract][Full Text] [Related]
15. Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor.
Fung HB; Kirschenbaum HL; Hameed R
Clin Ther; 2000 May; 22(5):549-72. PubMed ID: 10868554
[TBL] [Abstract][Full Text] [Related]
16. Experimental drug available.
Vazquez E
Posit Aware; 1998; 9(6):17. PubMed ID: 11366472
[TBL] [Abstract][Full Text] [Related]
17. Access to efavirenz and amprenavir.
Gilden D
GMHC Treat Issues; 1998 Oct; 12(10):12. PubMed ID: 11365902
[TBL] [Abstract][Full Text] [Related]
18. Amprenavir approved for HIV treatment.
Miller SL
Am J Health Syst Pharm; 1999 Jun; 56(11):1057-8. PubMed ID: 10385451
[No Abstract] [Full Text] [Related]
19. FDA notifications. FDA approves NDA for Lexiva.
AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960
[No Abstract] [Full Text] [Related]
20. FDA approves new dosing for amprenavir and ritonavir combination.
AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
